These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 15818683
1. MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Monk CR, Spachidou M, Rovis F, Leung E, Botto M, Lechler RI, Garden OA. Arthritis Rheum; 2005 Apr; 52(4):1180-4. PubMed ID: 15818683 [Abstract] [Full Text] [Related]
2. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. Parietti V, Monneaux F, Décossas M, Muller S. Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811 [Abstract] [Full Text] [Related]
3. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Kuhn A, Beissert S, Krammer PH. Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367 [Abstract] [Full Text] [Related]
4. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE. Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598 [Abstract] [Full Text] [Related]
5. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells. Tago F, Tsukimoto M, Nakatsukasa H, Kojima S. Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952 [Abstract] [Full Text] [Related]
6. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C. Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329 [Abstract] [Full Text] [Related]
7. Regulatory T cells in patients with systemic lupus erythematosus. Alvarado-Sánchez B, Hernández-Castro B, Portales-Pérez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda AC, González-Amaro R. J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406 [Abstract] [Full Text] [Related]
8. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S. J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [Abstract] [Full Text] [Related]
9. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S. Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [Abstract] [Full Text] [Related]
10. Conserved anti-proliferative effect and poor inhibition of TNFalpha secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus. Gómez J, Prado C, López P, Suárez A, Gutiérrez C. Clin Immunol; 2009 Sep; 132(3):385-92. PubMed ID: 19540813 [Abstract] [Full Text] [Related]
11. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Azab NA, Bassyouni IH, Emad Y, Abd El-Wahab GA, Hamdy G, Mashahit MA. Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252 [Abstract] [Full Text] [Related]
12. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Baráth S, Soltész P, Kiss E, Aleksza M, Zeher M, Szegedi G, Sipka S. Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042 [Abstract] [Full Text] [Related]
13. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL. Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064 [Abstract] [Full Text] [Related]
14. The role of CD4CD25 T cells in autoantibody production in murine lupus. Hsu WT, Suen JL, Chiang BL. Clin Exp Immunol; 2006 Sep; 145(3):513-9. PubMed ID: 16907921 [Abstract] [Full Text] [Related]
15. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Ahn JS, Krishnadas DK, Agrawal B. Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657 [Abstract] [Full Text] [Related]
16. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes. Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C. Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822 [Abstract] [Full Text] [Related]
17. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. Pyzik M, Piccirillo CA. J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784 [Abstract] [Full Text] [Related]
18. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Yang J, Chu Y, Yang X, Gao D, Zhu L, Yang X, Wan L, Li M. Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966 [Abstract] [Full Text] [Related]
19. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH. Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033 [Abstract] [Full Text] [Related]
20. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients. Hahn BH, Anderson M, Le E, La Cava A. Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553 [Abstract] [Full Text] [Related] Page: [Next] [New Search]